FDA Expands EUA for Pfizer-BioNTech COVID-19 Vaccine to Include 12-15-Year-Olds
The U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for the Pfizer-BioNTech COVID-19 Vaccine to include adolescents 12-15 years of age. From 3/1/2020 through 4/30/2021, approximately 1.5 million COVID-19 cases in individuals 11-17 years of …
FDA Expands EUA for Pfizer-BioNTech COVID-19 Vaccine to Include 12-15-Year-Olds Read more »
